Hosted on MSN2d
CVS Showered With Upgrades, PT Hikes After Q4 Beat Powers Stock To Best Day In Over 25 Years: Retail Cheer Grows
Shares of CVS Health Corp. continued climbing premarket Thursday after a blockbuster session driven by stronger-than-expected ...
CVS Health sees FY25 adjusted EPS $5.75-$6.00, consensus $5.97
Sees FY25 free cash flow $6.5B. The company said, “The Company issued its full-year 2025 GAAP diluted EPS guidance range of $4.58 to $4.83 and ...
CVS Health Q4 Earnings: Revenue And EPS Beat, Same-store Prescription Volume Up 5.9%, Upbeat FY25 Outlook And More
CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance ...
CVS Health (NYSE:CVS) Upgraded at Leerink Partnrs
Leerink Partnrs upgraded shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a strong-buy rating in a ...
CVS Health reports Q4 adjusted EPS $1.19, consensus 92c
Reports Q4 revenue $97.7B, consensus $96.88B. The company said, “Our integrated model allows us to uniquely deliver a simpler, connected ...
These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings
Adjusted EPS of $1.19 decreased from $2.12 in the prior year, beating the consensus of $0.93, primarily due to a decline in ...
5 Things to Know Before the Stock Market Opens
U.S. stock futures are little changed as investors watch for January inflation data, and Fed Chair Jerome Powell is set to ...
CVS Health targets $5.75-$6 EPS for 2025 amid Aetna recovery efforts and cost optimizations
Q4 2024 Management View CEO David Joyner highlighted the company's Q4 adjusted EPS of $1.19 and adjusted operating income of $2.7 billion. He introduced 2025 adjusted EPS guidance of $5.75 to $6.00, ...